Insider Selling: Celestica (NYSE:CLS) Director Sells 4,168 Shares of Stock

Celestica, Inc. (NYSE:CLSGet Free Report) (TSE:CLS) Director Michael Max Wilson sold 4,168 shares of the firm’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the completion of the transaction, the director owned 24,718 shares in the company, valued at $8,238,756.58. The trade was a 14.43% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Celestica Stock Performance

NYSE:CLS traded up $6.71 during midday trading on Wednesday, reaching $345.84. The stock had a trading volume of 1,714,266 shares, compared to its average volume of 2,416,743. Celestica, Inc. has a 1-year low of $110.54 and a 1-year high of $435.00. The firm’s fifty day simple moving average is $337.35 and its 200-day simple moving average is $316.63. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.26 and a quick ratio of 0.73. The stock has a market capitalization of $39.76 billion, a P/E ratio of 41.82, a PEG ratio of 0.79 and a beta of 2.09.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last posted its quarterly earnings results on Monday, April 27th. The technology company reported $2.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.08 by $0.08. The company had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. Celestica had a net margin of 6.95% and a return on equity of 36.91%. The business’s quarterly revenue was up 52.8% on a year-over-year basis. During the same period last year, the business posted $1.20 EPS. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. On average, equities research analysts forecast that Celestica, Inc. will post 9.5 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have issued reports on CLS shares. UBS Group raised their price target on shares of Celestica from $355.00 to $400.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. Barclays raised their price target on shares of Celestica from $391.00 to $441.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 29th. Citigroup raised their price target on shares of Celestica from $338.00 to $415.00 and gave the stock a “buy” rating in a research report on Wednesday, April 29th. TD Cowen upgraded shares of Celestica from a “hold” rating to a “buy” rating and raised their price target for the stock from $350.00 to $430.00 in a research report on Wednesday, April 29th. Finally, Canadian Imperial Bank of Commerce restated an “outperform” rating and issued a $480.00 price target on shares of Celestica in a research report on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $427.42.

Check Out Our Latest Research Report on CLS

Hedge Funds Weigh In On Celestica

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Norris Financial Group LLC bought a new position in shares of Celestica during the 1st quarter worth about $2,473,000. Bank of America Corp DE lifted its holdings in shares of Celestica by 10.8% during the 1st quarter. Bank of America Corp DE now owns 1,116,897 shares of the technology company’s stock worth $314,608,000 after acquiring an additional 108,926 shares during the period. Arkadios Wealth Advisors bought a new position in shares of Celestica during the 1st quarter worth about $290,000. Amundi lifted its holdings in shares of Celestica by 12.3% during the 1st quarter. Amundi now owns 213,552 shares of the technology company’s stock worth $60,153,000 after acquiring an additional 23,318 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Celestica by 8.2% during the 1st quarter. EverSource Wealth Advisors LLC now owns 569 shares of the technology company’s stock worth $160,000 after acquiring an additional 43 shares during the period. 67.38% of the stock is owned by institutional investors.

About Celestica

(Get Free Report)

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

See Also

Insider Buying and Selling by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.